We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
7.00 | 0.39% | 1,780.50 | 1,778.00 | 1,779.00 | 1,786.50 | 1,771.50 | 1,780.00 | 6,397,670 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.86 | 73.22B |
TIDMGSK
RNS Number : 5143H
GSK PLC
24 November 2022
GSK plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for 2023:
Results Announcement Ex-dividend Record date Last date Payable date date for DRIP elections Q1 2023 Wednesday 26 Thursday 18 Friday 19 Wednesday 21 Thursday 13 April 2023 May 2023 May 2023 June 2023 July 2023 --------------- --------------- --------------- -------------------- -------------- Q2 2023 Wednesday 26 Thursday 17 Friday 18 Wednesday 20 Thursday 12 July 2023 August 2023 August 2023 September 2023 October 2023 --------------- --------------- --------------- -------------------- -------------- Q3 2023 Wednesday 1 Thursday 16 Friday 17 Monday 18 December Thursday 11 November 2023 November 2023 November 2023 2023 January 2024 --------------- --------------- --------------- -------------------- -------------- Q4 2023 Wednesday 31 Thursday 22 Friday 23 Tuesday 19 Thursday 11 January 2024 February 2024 February 2024 March 2024 April 2024 (Final) --------------- --------------- --------------- -------------------- --------------
These dates are indicative and may be subject to change.
V A Whyte
Company Secretary
24 November 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DIVBKQBKDBDDDDB
(END) Dow Jones Newswires
November 24, 2022 10:00 ET (15:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions